Healthcare provider profile · identity verified

Lisa Bartels, MD

Family Practice · GEORGETOWN, DE · NPI 1548449754

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	472	135
Lisinopril	Lisinopril	332	89
Losartan Potassium	Losartan Potassium	268	74
Amlodipine Besylate	Amlodipine Besylate	238	74
Levothyroxine Sodium	Levothyroxine Sodium	233	60
Omeprazole	Omeprazole	212	60
Hydrochlorothiazide	Hydrochlorothiazide	195	59
Metoprolol Succinate	Metoprolol Succinate	192	52
Pantoprazole Sodium	Pantoprazole Sodium	157	40
Gabapentin	Gabapentin	148	53
Simvastatin	Simvastatin	134	36
Rosuvastatin Calcium	Rosuvastatin Calcium	123	40
Ozempic	Semaglutide	122	31
Pravastatin Sodium	Pravastatin Sodium	117	27
Duloxetine Hcl	Duloxetine Hcl	113	27
Metformin Hcl	Metformin Hcl	112	32
Montelukast Sodium	Montelukast Sodium	109	29
Escitalopram Oxalate	Escitalopram Oxalate	98	28
Tizanidine Hcl	Tizanidine Hcl	98	43
Prednisone	Prednisone	96	66
Furosemide	Furosemide	91	24
Famotidine	Famotidine	89	28
Synthroid	Levothyroxine Sodium	87	22
Tamsulosin Hcl	Tamsulosin Hcl	87	26
Trazodone Hcl	Trazodone Hcl	79	26
Albuterol Sulfate Hfa	Albuterol Sulfate	72	28
Fluticasone Propionate	Fluticasone Propionate	71	29
Alendronate Sodium	Alendronate Sodium	61	14
Allopurinol	Allopurinol	61	16
Jardiance	Empagliflozin	61	18
Meloxicam	Meloxicam	56	21
Bupropion Xl	Bupropion Hcl	55	14
Citalopram Hbr	Citalopram Hydrobromide	53	14
Venlafaxine Hcl Er	Venlafaxine Hcl	53	suppressed
Finasteride	Finasteride	52	15
Fluoxetine Hcl	Fluoxetine Hcl	52	15
Sumatriptan Succinate	Sumatriptan Succinate	47	suppressed
Methylprednisolone	Methylprednisolone	46	45
Trulicity	Dulaglutide	46	suppressed
Sertraline Hcl	Sertraline Hcl	44	13
Buspirone Hcl	Buspirone Hcl	43	15
Donepezil Hcl	Donepezil Hcl	43	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Baclofen	Baclofen	41	suppressed
Ezetimibe	Ezetimibe	41	13
Azithromycin	Azithromycin	38	33
Clopidogrel	Clopidogrel Bisulfate	38	12
Doxycycline Hyclate	Doxycycline Hyclate	38	32
Carvedilol	Carvedilol	37	11
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Estradiol	Estradiol	35	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Mounjaro	Tirzepatide	35	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	35	34
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	12
Valacyclovir	Valacyclovir Hcl	32	19
Eliquis	Apixaban	31	12
Ibuprofen	Ibuprofen	31	12
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Atenolol	Atenolol	27	suppressed
Celecoxib	Celecoxib	27	suppressed
Doxepin Hcl	Doxepin Hcl	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	21
Sucralfate	Sucralfate	27	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Valsartan	Valsartan	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Risperidone	Risperidone	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	13
Cephalexin	Cephalexin	22	17
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Colchicine	Colchicine	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Naproxen	Naproxen	16	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Ondansetron Odt	Ondansetron	15	12
Xarelto	Rivaroxaban	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Nystatin	Nystatin	14	suppressed
Topiramate	Topiramate	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Ramipril	Ramipril	13	suppressed
Victoza 3-Pak	Liraglutide	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Mupirocin	Mupirocin	12	12
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	11	suppressed
Ibu	Ibuprofen	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error